Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

NASDAQ:AEYE - US0507342014 - Common Stock

11.97 USD
-0.63 (-5%)
Last: 8/25/2025, 8:03:38 PM
12.09 USD
+0.12 (+1%)
After Hours: 8/25/2025, 8:03:38 PM
Fundamental Rating

3

AEYE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. AEYE has a bad profitability rating. Also its financial health evaluation is rather negative. AEYE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AEYE had negative earnings in the past year.
In the past year AEYE had a positive cash flow from operations.
In the past 5 years AEYE always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AEYE reported negative operating cash flow in multiple years.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

The Return On Assets of AEYE (-12.27%) is worse than 65.60% of its industry peers.
Looking at the Return On Equity, with a value of -56.62%, AEYE is doing worse than 71.63% of the companies in the same industry.
Industry RankSector Rank
ROA -12.27%
ROE -56.62%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

AEYE has a better Gross Margin (79.16%) than 77.66% of its industry peers.
In the last couple of years the Gross Margin of AEYE has grown nicely.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

2

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
AEYE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AEYE has been increased compared to 5 years ago.
Compared to 1 year ago, AEYE has an improved debt to assets ratio.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.39, we must say that AEYE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.39, AEYE is not doing good in the industry: 69.50% of the companies in the same industry are doing better.
AEYE has a debt to FCF ratio of 9.39. This is a negative value and a sign of low solvency as AEYE would need 9.39 years to pay back of all of its debts.
The Debt to FCF ratio of AEYE (9.39) is comparable to the rest of the industry.
AEYE has a Debt/Equity ratio of 1.74. This is a high value indicating a heavy dependency on external financing.
AEYE's Debt to Equity ratio of 1.74 is on the low side compared to the rest of the industry. AEYE is outperformed by 79.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 9.39
Altman-Z 0.39
ROIC/WACCN/A
WACC11.54%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.10 indicates that AEYE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.10, AEYE is doing worse than 68.09% of the companies in the same industry.
A Quick Ratio of 1.10 indicates that AEYE should not have too much problems paying its short term obligations.
The Quick ratio of AEYE (1.10) is worse than 67.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

AEYE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.43%.
AEYE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.52%.
Measured over the past years, AEYE shows a very strong growth in Revenue. The Revenue has been growing by 26.73% on average per year.
EPS 1Y (TTM)-46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
Revenue 1Y (TTM)18.52%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%16.38%

3.2 Future

Based on estimates for the next years, AEYE will show a very strong growth in Earnings Per Share. The EPS will grow by 60.53% on average per year.
Based on estimates for the next years, AEYE will show a quite strong growth in Revenue. The Revenue will grow by 16.30% on average per year.
EPS Next Y63.86%
EPS Next 2Y60.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.85%
Revenue Next 2Y16.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AEYE. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 59.27 indicates a quite expensive valuation of AEYE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AEYE is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.63. AEYE is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 59.27
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

AEYE's Enterprise Value to EBITDA is on the same level as the industry average.
AEYE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 107.8
EV/EBITDA 181.08
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

AEYE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AEYE's earnings are expected to grow with 60.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AEYE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUDIOEYE INC

NASDAQ:AEYE (8/25/2025, 8:03:38 PM)

After market: 12.09 +0.12 (+1%)

11.97

-0.63 (-5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners40.68%
Inst Owner Change-7.65%
Ins Owners32.96%
Ins Owner Change6.93%
Market Cap148.55M
Analysts81.82
Price Target22.64 (89.14%)
Short Float %6.81%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-695.49%
Min EPS beat(2)-1207.19%
Max EPS beat(2)-183.8%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-1.94%
Revenue beat(12)0
Avg Revenue beat(12)-2.01%
Revenue beat(16)0
Avg Revenue beat(16)-1.8%
PT rev (1m)-0.89%
PT rev (3m)-0.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-153.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.22%
Revenue NQ rev (3m)-5.64%
Revenue NY rev (1m)-2.49%
Revenue NY rev (3m)-2.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 59.27
P/S 3.88
P/FCF 107.8
P/OCF 45.17
P/B 20.21
P/tB N/A
EV/EBITDA 181.08
EPS(TTM)-0.41
EYN/A
EPS(NY)0.2
Fwd EY1.69%
FCF(TTM)0.11
FCFY0.93%
OCF(TTM)0.27
OCFY2.21%
SpS3.08
BVpS0.59
TBVpS-0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.27%
ROE -56.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.16%
FCFM 3.6%
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 9.39
Debt/EBITDA 14.23
Cap/Depr 57.27%
Cap/Sales 5%
Interest Coverage N/A
Cash Conversion 366.67%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.39
F-Score4
WACC11.54%
ROIC/WACCN/A
Cap/Depr(3y)70.6%
Cap/Depr(5y)93.23%
Cap/Sales(3y)5.53%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
EPS Next Y63.86%
EPS Next 2Y60.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.52%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%16.38%
Revenue Next Year14.85%
Revenue Next 2Y16.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year632.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y313.57%
OCF growth 3YN/A
OCF growth 5YN/A